- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-01-0017874

Dayra Pharmaceutical Private Limited
About Dayra Pharmaceutical Private Limited
Data last updated:
Dayra Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 March 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2022PTC395248.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohd Asim and Mohd Faizan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1101 3rd Floor Gali Chabuk Sawar Lal Kuan, Delhi, India – 110006.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.63 Lakh, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹1,621 (net margin 0.2%) and EBITDA of ₹2,297 (EBITDA margin 0.3%).
Dayra Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0017874).
Company details
Recognitions & Rankings of Dayra Pharmaceutical
Contact details
Dayra Pharmaceutical Private Limited's registered office is in Delhi, Delhi.
- Registered Address1101 3rd Floor Gali Chabuk Sawar Lal Kuan, Delhi, India – 110006
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dayra Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Dayra Pharmaceutical Private Limited, buy the company report.
Financials of Dayra Pharmaceutical Private Limited
FY 2025 filings availableDayra Pharmaceutical Private Limited reported revenue of ₹7.63 Lakh (up 40% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 40% in the latest year. EBITDA fell 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2,297 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1,621 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.3% | |||
| Net Profit Margin | 0.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Dayra Pharmaceutical Private Limited, buy the company report.
Board of directors of Dayra Pharmaceutical Private Limited
Dayra Pharmaceutical has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohd Asim | Director | 07 Nov 2022 | 3 Years 11 Months | Current |
| Mohd Faizan | Director | 21 Mar 2022 | 4 Years 7 Months | Current |
| Faheem Ahmed | Director | 21 Mar 2022 | 4 Years 7 Months | Current |
| Shaista | Director | 21 Mar 2022 | 4 Years 7 Months | Current |
Peer comparison
Dayra Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Khatra Rangamati Agro Producer Company Limited | ₹7.72 Lakh (FY 2024) | 545.0% | Raipur, West Bengal, India | |||
| Birdbrid Overseas Private Limited | ₹7.71 Lakh (FY 2025) | 293.0% | Etawah, Uttar Pradesh, India | |||
| Thermokine India Private Limited | ₹7.71 Lakh (FY 2025) | 13.0% | Domjur, West Bengal, India | |||
| Criff Pharma Private Limited | ₹7.66 Lakh (FY 2024) | 146.0% | Delhi, India | |||
| Aarya Industrial Solutions Private Limited | ₹7.65 Lakh (FY 2025) | -56.0% | Pune, Maharashtra, India | |||
| Dayra Pharmaceutical Private Limitedthis company | ₹7.63 Lakh (FY 2025) | ₹1,621 | 0.2% | 40.0% | Delhi, India | |
| Huli Jewellers Private Limited | ₹7.61 Lakh (FY 2025) | Ahore, Rajasthan, India | ||||
| Avsg Communications Private Limited | ₹7.61 Lakh (FY 2025) | -68.0% | New Delhi, Delhi, India | |||
| MK Polyplast Private Limited | ₹7.61 Lakh (FY 2024) | 608.0% | Ahmedabad, Gujarat, India | |||
| Namma Thota Traders Private Limited | ₹7.6 Lakh (FY 2025) | 32.0% | Yelahanka, Bangalore, Karnataka, India | |||
| Pali Grover Woollens Pvt Ltd | ₹7.6 Lakh (FY 2025) | -64.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Dayra Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dayra Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dayra Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dayra Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dayra Pharmaceutical Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Mohd Asim was appointed as Director on 07 Nov 2022.
Frequently asked questions
Dayra Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 March 2022 (4+ years old) and is registered under CIN U51909DL2022PTC395248.
Dayra Pharmaceutical has 4 current directors:
- Mohd Asim - Director
- Mohd Faizan - Director
- Faheem Ahmed - Director
- Shaista - Director
The latest financial statements of Dayra Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Dayra Pharmaceutical is U51909DL2022PTC395248. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dayra Pharmaceutical was incorporated on 21 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Dayra Pharmaceutical by revenue are Khatra Rangamati Agro Producer Company Limited, Birdbrid Overseas Private Limited, Thermokine India Private Limited, Criff Pharma Private Limited, Aarya Industrial Solutions Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Mohd Asim was appointed as Director on 07 Nov 2022. Faheem Ahmed was appointed as Director on 21 Mar 2022. Mohd Faizan was appointed as Director on 21 Mar 2022. Dayra Pharmaceutical has 4 board changes on record in total.
Yes, Dayra Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0017874).
The registered office of Dayra Pharmaceutical is at 1101 3rd Floor Gali Chabuk Sawar Lal Kuan, Delhi, India – 110006.
Dayra Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Dayra Pharmaceutical can be reached at its registered office: 1101 3rd Floor Gali Chabuk Sawar Lal Kuan, Delhi, India – 110006.

